Search research articles
Contact Us
Filters
Showing results (271-280 of 361) with videos related to
Page
of 37
Sort By:
Nature Communications
|
July 30, 2021
An integrated functional and clinical genomics approach reveals genes driving aggressive metastatic prostate cancer
Rajdeep Das, Martin Sjöström, Raunak Shrestha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2003
Improvements in quality of life and disease-related symptoms in phase I trials of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in non-small cell lung cancer and other solid tumors
Patricia M LoRusso, Roy S Herbst, Danny Rischin, et al.
Cancer Letters
|
June 26, 2016
An improved CTC isolation scheme for pairing with downstream genomics: Demonstrating clinical utility in metastatic prostate, lung and pancreatic cancer
Gayatri Premasekharan, Elizabeth Gilbert, Ross A Okimoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 5, 2015
Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome
Debraj GuhaThakurta, Nadeem A Sheikh, Li-Qun Fan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 2015
Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer
Arun A Azad, Stanislav V Volik, Alexander W Wyatt, et al.
Journal of the National Cancer Institute
|
December 6, 2017
Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer
Alexander W Wyatt, Matti Annala, Rahul Aggarwal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 4, 2008
Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group
Howard I Scher, Susan Halabi, Ian Tannock, et al.
Molecular Cancer Research : MCR
|
March 29, 2019
Whole-Genome and Transcriptional Analysis of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer Demonstrates Intraclass Heterogeneity
Rahul R Aggarwal, David A Quigley, Jiaoti Huang, et al.
European Urology Oncology
|
May 6, 2025
Niraparib and Abiraterone Acetate plus Prednisone in Metastatic Castration-resistant Prostate Cancer: Final Overall Survival Analysis for the Phase 3 MAGNITUDE Trial
Kim N Chi, Elena Castro, Gert Attard, et al.
The New England Journal of Medicine
|
February 9, 2018
Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer
Matthew R Smith, Fred Saad, Simon Chowdhury, et al.
Page
of 37
Search research articles
Search
Showing results (271-280 of 361) with videos related to
Sort By:
Page
of 37
Nature Communications
|
July 30, 2021
An integrated functional and clinical genomics approach reveals genes driving aggressive metastatic prostate cancer
Rajdeep Das, Martin Sjöström, Raunak Shrestha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2003
Improvements in quality of life and disease-related symptoms in phase I trials of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in non-small cell lung cancer and other solid tumors
Patricia M LoRusso, Roy S Herbst, Danny Rischin, et al.
Cancer Letters
|
June 26, 2016
An improved CTC isolation scheme for pairing with downstream genomics: Demonstrating clinical utility in metastatic prostate, lung and pancreatic cancer
Gayatri Premasekharan, Elizabeth Gilbert, Ross A Okimoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 5, 2015
Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome
Debraj GuhaThakurta, Nadeem A Sheikh, Li-Qun Fan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 2015
Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer
Arun A Azad, Stanislav V Volik, Alexander W Wyatt, et al.
Journal of the National Cancer Institute
|
December 6, 2017
Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer
Alexander W Wyatt, Matti Annala, Rahul Aggarwal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 4, 2008
Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group
Howard I Scher, Susan Halabi, Ian Tannock, et al.
Molecular Cancer Research : MCR
|
March 29, 2019
Whole-Genome and Transcriptional Analysis of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer Demonstrates Intraclass Heterogeneity
Rahul R Aggarwal, David A Quigley, Jiaoti Huang, et al.
European Urology Oncology
|
May 6, 2025
Niraparib and Abiraterone Acetate plus Prednisone in Metastatic Castration-resistant Prostate Cancer: Final Overall Survival Analysis for the Phase 3 MAGNITUDE Trial
Kim N Chi, Elena Castro, Gert Attard, et al.
The New England Journal of Medicine
|
February 9, 2018
Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer
Matthew R Smith, Fred Saad, Simon Chowdhury, et al.
Page
of 37